Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of International Oncology
>
2012
>
39
>
3
Volume:
39
Issue:
3
1. BRAFV600E gene mutation in papillary thyroid cancer
Page:206—208
2. Biological function of Securin and prospect for research in tumor
Page:176—179
3. EZH2 gene and cancer
Page:182—186
4. Advance of the targeted anti-tumor drugs with small molecule compounds
Page:172—175
5. Molecular mechanism of cisplatin resistance in ovarian cancer
Page:234—236
6. Helicobacter pylori and colorectal cancer
Page:228—230
7. Treatment of hepatocellular carcinoma with portal vein tumor thrombus
Page:225—227
8. Mammalian target of rapamycin in gastric cancer
Page:222—224
9. Application of epidermal growth factor receptor for radiotherapy of esophageal cancer
Page:218—220
10. EMLA-ALK fusion gene in non-small cell lung cancer
Page:212—214
11. Therapy of triple negative breast cancer
Page:209—211
12. Epidermal growth factor receptor Ⅲ variant and targeted therapy of glioblastoma
Page:200—202
13. Radiosensitizing effect of natural active product on tumor
Page:196—200
14. Gene targeting diagnosis and treatment in cancer
Page:186—189
15. Mechanism of polarity proteins regulate tumorigenesis
Page:179—182
16. Function and advance of GPR30 in hormone-related neoplasms
Page:166—169
17. Diagnostic application value of urothelial carcinoma of the urinary bladder by dual color fluorescence in-situ hybridization
Page:237—240
18. Progress of the angiogenesis correlation factors for endometrial carcinoma
Page:230—233
19. HMGB1 and gastric cancer
Page:220—222
20. Different fractionations of radiotherapy in non-small cell lung cancer
Page:215—217
21. Variety of molecular mechanisms of cisplatin in the treatment of nasopharyngeal carcinoma
Page:203—205
22. Application of nanoparticle vectors in photodynamic therapy of tumors
Page:193—196
23. Antiangiogenic therapy for PTCL
Page:190—193
24. Advances of tumor-associated fibroblasts in carcinogenesis
Page:163—166
25. Aminopeptidase N and its inhibitors and carcinoma
Page:169—171,233